Financial statements Bioalter

Balance sheet of Bioalter

Company age:
Age:
16 y. 9 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of BIOALTER

Year
2018
2019
2020
2021
2022
2023
Total assets 8 958 560,10 9 621 989,78 13 267 322,99 11 982 532,50 6 344 523,97 7 122 046,89
A. Fixed assets 3 303 111,01 2 658 005,86 3 710 719,03 3 318 133,44 3 199 464,89 2 922 146,65
B. Current assets 5 655 449,09 6 963 983,92 9 556 603,96 8 664 399,06 3 145 059,08 4 199 900,24
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 8 958 560,10 9 621 989,78 13 267 322,99 11 982 532,50 6 344 523,97 7 122 046,89
A. Equity -4 598 788,71 -3 714 582,47 -4 751 328,04 -4 591 688,50 -3 659 978,96 -2 721 990,75
B. Liabilities and provisions for liabilities 13 557 348,81 13 336 572,25 18 018 651,03 16 574 221,00 10 004 502,93 9 844 037,64
I. Long-term liabilities 6 414 572,21 8 879 586,82 12 666 782,92 12 125 044,19 8 752 794,64 8 261 502,74
II. Short-term liabilities 5 730 698,71 3 649 542,42 5 149 059,98 4 449 176,81 1 251 708,29 1 582 534,90
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.